Eiger BioPharmaceuticals, Inc.
(NASDAQ : EIGR)

( )
EIGR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.79%171.561.2%$575.26m
CELGCelgene Corporation
-0.75%88.951.2%$554.24m
GILDGilead Sciences, Inc.
-0.99%73.700.9%$441.10m
BIIBBiogen Inc.
-1.13%263.021.2%$436.72m
REGNRegeneron Pharmaceuticals, Inc.
-0.50%314.252.7%$242.24m
INCYIncyte Corporation
-0.90%68.432.5%$236.48m
VRTXVertex Pharmaceuticals Incorporated
-0.88%158.151.9%$224.32m
ALXNAlexion Pharmaceuticals, Inc.
-3.54%107.782.0%$215.70m
NKTRNektar Therapeutics
-4.37%86.216.0%$196.49m
ILMNIllumina, Inc.
-0.50%244.603.5%$185.23m
AAgilent Technologies, Inc.
-0.63%67.541.5%$152.87m
ALNYAlnylam Pharmaceuticals, Inc
1.34%97.489.8%$137.98m
BLUEBluebird Bio, Inc.
0.00%170.5015.8%$135.45m
EXASExact Sciences Corporation
1.54%47.5225.7%$108.85m
BMRNBioMarin Pharmaceutical Inc.
-1.58%82.304.4%$107.66m

Company Profile

Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for orphan diseases. It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.